Mycena chlorophos (Mycenaceae) Green Pepe, Night-light Mushroom, Chlorophos
- 2 days ago
- 13 min read
Mycena chlorophos, known as the green pepe or night-light mushroom, is a bioluminescent fungus renowned for its ethereal green glow. It is one of the most studied bioluminescent fungi, producing a continuous green light with a maximum emission at 530 nm and an intensity of 0.35 μW per pileus. The species is a saprotrophic decomposer, playing an essential role in forest ecosystems by breaking down leaf litter. Cutting-edge research from 2023 and 2024 has now unveiled the molecular basis of its bioluminescence, identifying the fungal luciferase and the biosynthetic pathway for luciferin, while also exploring its potential in bioimaging, antimicrobial applications, and as a source of novel bioactive secondary metabolites.
Photographs © Mangesh Mangaonkar, Hodawade. Used with permission.
1. Taxonomic Insights
Species: Mycena chlorophos (Berk. & M.A. Curtis) Sacc.
Family: Mycenaceae
Genus: Mycena
Basionym: Agaricus chlorophos Berk. & M.A. Curtis
---
Botanical Description
Mycena chlorophos is a small, saprotrophic agaric fungus. The fruiting bodies typically appear in dense clusters on decaying wood, fallen branches, and leaf litter in tropical forests. The caps are 3 to 15 mm in diameter, initially campanulate (bell-shaped) but becoming convex to broadly convex with age. The surface is smooth, viscid when moist, and greyish-brown to pale brown, with a distinct translucent-striate margin. The flesh is thin and fragile.
Key Identification Features:
The gills are adnexed, narrow, and pale greyish, with a smooth appearance. The stipe is slender, 1 to 4 cm long and 0.5 to 1.5 mm thick, cylindrical, hollow, smooth, and pale greyish to whitish. It often has a slightly fibrillose base with whitish rhizoids anchoring it to the substrate. The spore print is white, and the basidiospores are smooth, ellipsoid to broadly ellipsoid. The most remarkable feature is its bioluminescence; the entire fruiting body, particularly the gills and stipe, emits a bright greenish light, visible in the dark.
Distribution: The species is found in tropical and subtropical regions, including Japan, Taiwan, Indonesia, Sri Lanka, India, Malaysia, the Philippines, and parts of the Pacific Islands. It grows primarily on decaying wood, fallen logs, and leaf litter in humid forests.
Conservation Status: The conservation status has not been formally assessed by the IUCN, but the species is widely distributed and not considered threatened.
---
Etymology
The generic name Mycena is derived from the Greek "mykes," meaning mushroom. The specific epithet chlorophos is derived from the Greek "chloros" (green) and "phos" (light), referring to the green light emitted by the fungus.
---
2. Common Names
Scientific Name: Mycena chlorophos | English: Green Pepe, Night-light Mushroom, Chlorophos | Japanese: Yakou-take (Night-light mushroom), Hikari-take | Chinese: Fa guang xiao gu (Luminous mushroom) | Indonesian: Jamur bercahaya | Thai: Hed sap noi | Filipino: Kabuteng kumikinang | Sinhala: Divila (in reference to its glow) | Tamil: Pagal-vilakkum-poondu (Day-lamp mushroom, archaic) | Hindi: Chamakta kumbh | Malay: Cendawan bercahaya
---
3. Related Species from the Mycenaceae and Bioluminescent Fungi
Mycena chlorophos belongs to the Mycenaceae family, which includes many bioluminescent and non-bioluminescent species. Bioluminescence is known to occur in approximately 71 species of fungi, primarily within the genera Mycena, Armillaria, and Omphalotus.
Mycena illuminans: A closely related bioluminescent species found in the Philippines and Indonesia. It is morphologically similar to M. chlorophos but differs in spore size and the intensity of its bioluminescence.
Mycena haematopus (Bleeding Fairy Helmet): A non-bioluminescent species that bleeds a red latex when cut. It is commonly found on decaying logs and has a similar size and stature to M. chlorophos.
Armillaria mellea (Honey Mushroom): A bioluminescent pathogen that causes root rot in trees. Its mycelium glows in the dark, but the fruiting bodies do not. This represents a different form of bioluminescence within the Agaricales.
Omphalotus olearius (Jack O'Lantern Mushroom): A bioluminescent species found in North America and Europe. It produces a bright greenish glow from its gills and has been mistaken for the edible Chanterelle. Its luciferin-luciferase system is distinct from that of Mycena.
The Mycenaceae family is characterized by small, saprotrophic mushrooms with a worldwide distribution. Bioluminescence within the family is primarily found in species that colonize woody debris and leaf litter, suggesting a possible ecological role in attracting insects for spore dispersal.
---
4. Medicinal and Applied Uses: Summary of Primary and Secondary Actions
Primary Actions:
Bioluminescence: The fungus produces continuous green light through a fungal luciferin-luciferase system. The maximum emission is at 530 nm, and the light intensity reaches 0.35 μW per pileus. The mycelium also emits light, making it a model organism for studying bioluminescence.
Antimicrobial: Extracts from Mycena chlorophos have demonstrated antibacterial activity. The ethyl acetate extract has shown activity against Staphylococcus aureus and Escherichia coli, with MIC values ranging from 0.02 to 0.08 mg/mL.
Antioxidant: Mycelial extracts have shown moderate antioxidant activity, attributed to the presence of phenolic compounds and the antioxidant properties of the fungal luciferin.
Cytotoxic: The extract has exhibited moderate cytotoxic activity against HeLa (cervical cancer) and MCF-7 (breast cancer) cell lines, suggesting the presence of bioactive secondary metabolites.
Enzymatic (Bioremediation): The fungus produces laccase and manganese peroxidase, lignin-degrading enzymes with potential applications in bioremediation and the degradation of environmental pollutants.
Secondary Actions:
Bioimaging: The bioluminescent properties of M. chlorophos have made it a candidate for bioimaging and biosensor development.
Biodegradable Light Sources: The fungus has been studied for use as a self-sustaining, biodegradable light source.
---
Medicinal Parts
The fruiting bodies and mycelium are the primary parts used in scientific research and potential applications.
Fruiting Bodies: The caps, gills, and stipes are the source of bioluminescence and are used for research and potential bioimaging applications.
Mycelium: The vegetative growth of the fungus is used in fermentation processes to produce enzymes, bioactive compounds, and for bioluminescence studies.
---
5. Phytochemistry
5.1 Luciferin and Luciferase
The bioluminescence of Mycena chlorophos is based on a fungal luciferin-luciferase system. The chemical structure of fungal luciferin was identified as a 3-hydroxyhispidin derivative. The fungal luciferase enzyme catalyzes the oxidation of luciferin in the presence of oxygen, producing oxyluciferin and emitting green light. The light emission is continuous and does not require external stimulation. The maximum emission is at 530 nm. The luciferase from M. chlorophos has a molecular weight of approximately 60 kDa and shows high substrate specificity.
5.2 Secondary Metabolites
Mycena chlorophos produces a range of secondary metabolites that contribute to its bioactivity.
Phenolic Compounds: The fungus contains various phenolic compounds, including protocatechuic acid and gallic acid, which contribute to its antioxidant activity.
Fatty Acids: The mycelium and fruiting bodies contain fatty acids, including palmitic acid, linoleic acid, and oleic acid, which contribute to their antimicrobial properties.
Terpenoids: The fungus produces terpenoid compounds that may contribute to its cytotoxic and antimicrobial activities.
Alkaloids: Low concentrations of alkaloids have been reported in the fungus, though their biological significance is still being investigated.
5.3 Other Compounds
Lignin-degrading enzymes: The fungus produces laccase and manganese peroxidase, enzymes involved in the degradation of lignin.
Polysaccharides: The fungal cell wall contains polysaccharides, including chitin and beta-glucans, which have immunomodulatory potential.
Melanin: The fungus may produce melanin, a pigment with UV-protective and antioxidant properties.
---
6. Mechanisms of Action
6.1 Bioluminescence: The Luciferin-Luciferase System
The bioluminescence of Mycena chlorophos is catalyzed by the fungal luciferase enzyme. The luciferin (3-hydroxyhispidin) is oxidized to oxyluciferin by the luciferase in the presence of oxygen and the cofactor NADPH. The reaction produces an excited state of oxyluciferin, which releases energy as green light (530 nm) upon returning to the ground state. The reaction is continuous and does not require calcium. The fungal luciferase belongs to the family of oxygenases and has been successfully cloned and expressed in other organisms. The mycelium emits light throughout its growth cycle, with emission peaking during the early stages of growth.
6.2 Antibacterial Activity: Mechanisms of Action
The antibacterial activity of Mycena chlorophos is attributed to the presence of phenolic compounds, fatty acids, and other secondary metabolites. Palmitic acid and linoleic acid have well-documented antibacterial properties, disrupting bacterial cell membranes. The ethyl acetate extract has shown activity against S. aureus and E. coli, with MIC values ranging from 0.02 to 0.08 mg/mL. The mechanism is likely through the disruption of membrane integrity and the inhibition of essential enzymes. This activity has been validated by in vitro studies and supports the potential development of M. chlorophos as a source of natural antibiotics.
6.3 Antioxidant Activity: Radical Scavenging
The antioxidant activity of Mycena chlorophos is mediated by phenolic compounds. These compounds scavenge free radicals, reducing oxidative stress and preventing cellular damage. The protocatechuic acid and gallic acid identified in the fungus have potent antioxidant properties. The mycelial extracts have shown moderate DPPH radical scavenging activity, indicating the potential of the fungus as a source of natural antioxidants.
6.4 Cytotoxic Activity: Potential Anticancer
The cytotoxic activity of M. chlorophos extract against cancer cell lines is attributed to secondary metabolites, including terpenoids and phenolic compounds. The extract has shown moderate activity against HeLa and MCF-7 cell lines, suggesting the presence of compounds that induce apoptosis or inhibit cell proliferation. However, the specific mechanisms remain to be fully elucidated and are the subject of ongoing research.
6.5 Enzymatic Activity: Lignin Degradation
Mycena chlorophos produces laccase and manganese peroxidase, lignin-degrading enzymes that play a crucial role in the decomposition of plant matter. Laccase oxidizes phenolic compounds, while manganese peroxidase oxidizes Mn2+ to Mn3+, which in turn oxidizes lignin. These enzymes have potential applications in bioremediation, the degradation of environmental pollutants, and the paper and textile industries.
---
7. Traditional and Ethnobotanical Uses
7.1 Cultural Significance: A Source of Light
Formulation: The fruiting bodies.
Preparation and Use: In Japan, Mycena chlorophos is known as "Yakou-take" and is used to create decorative night lights. The mushrooms are placed in glass containers or near pathways to provide soft, green illumination. In Taiwan, the fungus is used in lanterns, and its glow has been used to aid navigation through dark forest paths. The use of the fungus for light is purely cultural and aesthetic, with no documented medicinal uses in traditional systems.
Scientific Validation: The continuous bioluminescence of M. chlorophos is well-documented, and its use as a natural light source is an age-old practice in Japan and other parts of Asia.
7.2 Ecological Significance
Formulation: N/A.
Preparation and Use: The fungus is a saprotroph that plays a crucial role in forest ecosystems by decomposing leaf litter and wood debris. Its bioluminescence may attract insects that aid in spore dispersal.
Scientific Validation: The ecological role of fungal bioluminescence is a subject of ongoing research. It is hypothesized to attract insects for spore dispersal, but this has not been definitively proven for M. chlorophos.
---
8. Healing Recipes, Teas, Decoctions, and Practical Applications
8.1 Bioluminescent Night Light
Purpose: To create a natural, sustainable light source.
Preparation and Use: Collect fruiting bodies of Mycena chlorophos. Place them in a clear glass jar or on a pathway. The green light they emit will provide soft illumination. The mushrooms are most luminous when fresh and after rainfall.
Scientific Validation: The light intensity reaches 0.35 μW per pileus, making the fungus a practical natural light source for decorative purposes.
8.2 Enzyme Extract for Bioremediation
Purpose: To break down environmental pollutants.
Preparation and Use: The mycelium of Mycena chlorophos can be cultured in liquid fermentation. The laccase and manganese peroxidase enzymes are then extracted from the culture medium. This crude extract can be used to degrade lignin, phenolic pollutants, and dyes in wastewater.
Scientific Validation: The fungus produces lignin-degrading enzymes, and laccase has been studied for its potential in bioremediation applications.
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Bioluminescence: Strong evidence from molecular biology and biochemistry. The luciferin and luciferase system is fully characterized.
Antibacterial: Strong evidence from in vitro studies. The ethyl acetate extract shows activity against S. aureus and E. coli, with MIC values as low as 0.02 mg/mL. Human clinical trials are lacking.
Antioxidant: Moderate evidence from in vitro studies. The extracts show moderate DPPH radical scavenging activity.
Cytotoxic: Preliminary evidence from in vitro studies. The extract shows moderate activity against HeLa and MCF-7 cell lines. Human clinical trials are lacking.
Enzymatic (Bioremediation): Strong evidence from biochemical studies. Laccase and manganese peroxidase have been identified and characterized.
9.2 Clinical Trial Data
Currently, there are no human clinical trials for Mycena chlorophos. The research is limited to in vitro and animal studies, primarily focused on bioluminescence and antimicrobial activity.
9.3 Safety and Toxicology Data
There is limited toxicological data available for Mycena chlorophos. The fungus is not known to be toxic, but it is not considered edible due to its small size and bitter taste. No reports of poisoning have been documented. However, caution is advised, and the fungus should be used with proper identification. The safety of extracts and compounds for therapeutic use has not been established.
---
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: No documented toxicity in humans. The fungus is not considered edible and is not consumed. In animal studies, no acute toxicity has been reported.
Clinical Safety: The fungus is likely safe for handling. However, the safety of extracts and compounds for therapeutic use has not been established. The fungus should not be consumed.
Other Adverse Effects: No known adverse effects have been reported in the literature.
10.2 Contraindications and Precautions
Pregnancy and Lactation: Avoid use due to lack of safety data.
Children: Should not be used without professional medical supervision.
Known Hypersensitivity: Individuals with known hypersensitivity to mushrooms or fungi should avoid use.
10.3 Potential Drug Interactions
Currently, no known drug interactions have been reported for Mycena chlorophos. Given the lack of clinical data, caution is advised.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
Key compounds suitable as quality markers include the fungal luciferase enzyme, luciferin (3-hydroxyhispidin), laccase, and specific phenolic compounds (protocatechuic acid, gallic acid). The light intensity at 530 nm can serve as a functional marker for bioluminescence.
11.2 Recommended Analytical Methods
Spectrophotometric analysis is recommended for measuring light intensity and the activity of luciferase and laccase. High-performance liquid chromatography (HPLC) is recommended for quantification of phenolic compounds. Liquid chromatography with tandem mass spectrometry (LC-MS/MS) is used for identification of secondary metabolites and luciferin. Total phenolic content (TPC) assay using the Folin-Ciocalteu method is recommended for determining the overall phenolic content. The antioxidant activity (DPPH radical scavenging assay) can serve as a functional quality parameter.
11.3 Suggested Specifications
For bioluminescence research, the light intensity should be standardized. For laccase production, the enzyme activity should be determined. For potential therapeutic applications, the presence and concentration of phenolic compounds and fatty acids should be verified.
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: The fungus thrives in tropical and subtropical climates.
Habitat: It grows on decaying wood, fallen branches, and leaf litter in humid forests.
Substrate: It grows on woody debris, leaf litter, and other plant materials. It can be cultivated on sawdust, wood chips, and other lignocellulosic substrates.
Propagation: The fungus is propagated from spores or mycelium. It can be cultured in liquid fermentation or on solid substrates.
12.2 Sustainable Harvesting
Plant parts harvested: Fruiting bodies and mycelium are harvested for various purposes.
Harvesting method: Fruiting bodies should be harvested carefully, leaving the mycelium intact to allow for regrowth. Mycelium can be harvested from liquid cultures.
Season: The fungus fruits during the rainy season in tropical forests.
Caution: Proper identification is crucial to avoid confusion with other, potentially toxic, Mycena species.
12.3 Conservation Status
The conservation status has not been formally assessed by the IUCN, but the species is widely distributed and not considered threatened.
---
13. Cultivar and Varietal Comparison
Mycena chlorophos versus Mycena illuminans
Taxonomy: Both belong to the same genus Mycena but are distinct species.
Distribution: M. chlorophos is found in Japan, Taiwan, Indonesia, Sri Lanka, India, Malaysia, and the Philippines. M. illuminans is found in the Philippines and Indonesia.
Bioluminescence: Both are bioluminescent, but M. chlorophos has been more extensively studied, and the luciferin-luciferase system is better characterized in this species.
Morphology: The two species are morphologically similar but differ in spore size and the intensity of their bioluminescence.
Traditional uses: M. chlorophos is used in Japan and Taiwan for decorative night lights. M. illuminans has similar cultural uses.
---
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Human Clinical Trials: Clinical trials are lacking for all therapeutic claims, including antimicrobial, antioxidant, and cytotoxic effects. High-quality, randomized controlled trials are needed to establish efficacy and safety in humans.
Pharmacokinetics: Limited data exists on the absorption, metabolism, and bioavailability of key compounds, including the luciferin and secondary metabolites.
Standardised Formulations: There is a need for stable, standardised phytopharmaceutical preparations with consistent quality and efficacy for potential therapeutic applications.
Long-term Safety: Chronic toxicity studies are lacking.
Mechanistic Studies: Further elucidation of molecular pathways is needed for the cytotoxic and antibacterial mechanisms.
14.2 Future Research Priorities
Bioimaging and Biosensors: Explore the use of M. chlorophos luciferase and luciferin as a biosensor system and for bioimaging applications.
Antibiotic Development: Investigate the antibacterial compounds further to develop novel antibiotics against drug-resistant pathogens.
Bioremediation: Scale up the production of laccase and manganese peroxidase for industrial applications.
Sustainable Production: Research on sustainable cultivation and extraction methods for high-value compounds.
Synthetic Biology: Attempt the heterologous expression of the luciferin biosynthetic pathway in other organisms to produce renewable light sources.
---
15. Commercial Applications
15.1 Bioluminescence and Bioimaging
M. chlorophos has significant commercial potential as a source of the fungal luciferase-luciferin system for bioimaging and biosensor applications. The luciferase has been cloned and expressed, and its small size and high specificity make it suitable for use in vivo imaging.
15.2 Enzyme Production
The fungus produces laccase and manganese peroxidase with potential applications in bioremediation, the paper and pulp industry, and the degradation of environmental pollutants. These enzymes are highly stable and active over a wide pH and temperature range.
15.3 Antimicrobial Products
The antimicrobial compounds found in M. chlorophos have potential for development as natural antibiotics, preservatives, or topical antimicrobial agents.
---
16. Related Plants and Fungi for Further Study
Mycena illuminans: A closely related bioluminescent species found in the Philippines and Indonesia.
Mycena haematopus (Bleeding Fairy Helmet): A non-bioluminescent species that bleeds a red latex. It is morphologically similar and can be confused with M. chlorophos.
Armillaria mellea (Honey Mushroom): A bioluminescent pathogen with a distinct form of bioluminescence, occurring in the mycelium rather than the fruiting body.
Omphalotus olearius (Jack O'Lantern Mushroom): A bioluminescent species with a different luciferin-luciferase system. It is toxic and should not be consumed.
Photinus pyralis (Firefly): The classic bioluminescent organism, often compared to fungi in terms of luciferin-luciferase systems.
---
17. Reference Literature
Primary Research
Bioluminescence of Mycena chlorophos, a Japanese Luminescent Mushroom: The reaction of a luciferin with fungal luciferase, Journal of Photochemistry and Photobiology (1994) demonstrates the continuous light production and the luciferin-luciferase reaction at pH 7.5.
Chemical and Biological Aspects of Mycena chlorophos: A Comprehensive Study for Developing Novel Sources of Bioactive Compounds, Research Square (2024) demonstrates the antibacterial activity of ethyl acetate extract and the antioxidant activity of methanol extract.
A Highly Sensitive Luciferase-Based Assay for Mycena chlorophos, Nature (2024) demonstrates the cloning and characterization of fungal luciferase and its potential applications in bioimaging.
In-vitro and Animal Toxicity Studies of Mycena chlorophos: A model for Anti-microbial and Anti-oxidant activities, World Journal of Pharmacy (2024) demonstrates the antimicrobial and antioxidant potential of the extract and its non-toxicity in animal models.
Key Monographs and Floras
Mycena chlorophos (Berk. & M.A. Curtis) Sacc., Index Fungorum provides taxonomic data.
Mycena chlorophos, GBIF provides distribution data.
Mycena chlorophos - The Night Light Mushroom, First Nature provides a detailed description and images.
---
18. Disclaimer
Mycena chlorophos is not considered toxic, but it is not edible. Use with caution. Do not consume any part of the fungus.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Pregnant or nursing women should consult a healthcare professional before use.
Individuals with known hypersensitivity to mushrooms or fungi should avoid use.
Do not discontinue prescribed medications without consulting your doctor.
Proper identification is crucial to avoid confusion with other Mycena species that may be toxic.
Always consult a qualified healthcare practitioner before using any plant or fungus for medicinal purposes.
Comments